This comment shows how ignorant you are when it comes to the cancer biotech space. It's how you advance to the clinic. Every company in this space needs to do it.
Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-22
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
-0.005(0.36%) |
Mkt cap ! $227.8M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $23.84K | 17.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 285 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 1800 | 1 |
View Market Depth
| Last trade - 10.57am 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.40 |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| $1.36 | $1.40 | $1.36 | 10857 | ||
| Last updated 10.57am 29/05/2024 ? | |||||
| RAC (ASX) Chart |